SIAP
JAZZ icon

Sterling Investment Advisors (Pennsylvania)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed -$1K – 586
2021
Q3 		$1K Hold
4
– – ﹤0.01% 548
2021
Q2 		$1K Buy
+4
New +$693 ﹤0.01% 517

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s JAZZ Position: Q4 2021 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 4 shares — an estimated $1K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in JAZZ in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 4 Jazz Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Jazz Pharmaceuticals position peaked at $1K in Q3 2021.
  • 454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q4 2021, filed 2 Feb 2022.